Imapct of Clonal Hematopoiesis of Indeterminate Potential (CHIP) Associated Mutations and Risk of Comorbidities in Patients with Myelodysplastic Syndrome

被引:0
|
作者
Naqvi, Kiran [1 ]
Sasaki, Koji [1 ]
Montalban-Bravo, Guillermo [1 ]
Alfonso, Ana [1 ]
Yilmaz, Musa [1 ]
Short, Nicholas J. [1 ]
Assi, Rita [1 ]
Jabbour, Elias J. [1 ]
Ravandi, Farhad [1 ]
Kadia, Tapan M. [1 ]
Pierce, Sherry A. [1 ]
Takahashi, Koichi [1 ]
Gonzalez, Graciela M. Nogueras [2 ]
Kanagal-Shamanna, Rashmi [3 ]
Patel, Keyur P. [3 ]
Kantarjian, Hagop M. [1 ]
Garcia-Manero, Guillermo [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
关键词
D O I
10.1182/blood-2018-99-117112
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1814
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Clonal Hematopoiesis of Indeterminate Potential - Associated Mutations and Risk of Comorbidities in Patients with Myelodysplastic Syndrome
    Naqvi, Kiran
    Bravo, Guillermo Montalban
    Pierola, Ana Alfonso
    Yilmaz, Musa
    Sasaki, Koji
    Short, Nicholas J.
    Assi, Rita
    Jabbour, Elias J.
    Ravandi, Farhad
    Benton, Christopher B.
    Kadia, Tapan
    Pierce, Sherry
    Borthakur, Gautam
    Daver, Naval
    DiNardo, Courtney D.
    Takahashi, Koichi
    Jain, Nitin
    Pemmaraju, Naveen
    Gonzalez, Graciela Nogueras
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    BLOOD, 2017, 130
  • [2] Clonal hematopoiesis of indeterminate potential-associated mutations and risk of comorbidities in patients with myelodysplastic syndrome
    Naqvi, Kiran
    Sasaki, Koji
    Montalban-Bravo, Guillermo
    Pierola, Ana Alfonso
    Yilmaz, Musa
    Short, Nicholas
    Assi, Rita
    Jabbour, Elias
    Ravandi, Farhad
    Kadia, Tapan
    Pierce, Sherry
    Takahashi, Koichi
    Gonzalez, Graciela Nogueras
    Kanagal-Shamanna, Rashmi
    Patel, Keyur
    Soltysiak, Kelly A.
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    CANCER, 2019, 125 (13) : 2233 - 2241
  • [3] High prevalence of clonal hematopoiesis of indeterminate potential (CHIP) associated mutations in elderly patients with solid tumors
    Rodriguez, J. E.
    Bayle, A.
    Pages, A.
    Danlos, F-X.
    Vasseur, D.
    Rouleau, E.
    Lacroix, L.
    Goldschmidt, V.
    Seknazi, L.
    Hollebecque, A.
    Michot, J-M.
    Champiat, S.
    Marabelle, A.
    Postel-Vinay, S.
    Ouali, K.
    Marzac, C.
    Ponce, S.
    Italiano, A.
    Micol, J. Baptiste
    Baldini, C.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S775 - S775
  • [4] Thrombotic significance in plasma cell disorders: do associated clonal hematopoiesis of indeterminate potential (CHIP) mutations increase the risk?
    Vankina, Ritika
    Kirk, Kaylyn
    Hooper, Katharine
    Reddy, Aswanth
    Kumar, Swarup
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S91 - S91
  • [5] Significance of Gene Mutations in the Evaluation of Patients with Pancytopenia: Impact of Clonal Hematopoiesis of Indeterminate Potential (CHIP)
    Fernandez-Pol, Sebastian
    Ma, Lisa
    Arber, Daniel A.
    LABORATORY INVESTIGATION, 2016, 96 : 344A - 344A
  • [6] Significance of Gene Mutations in the Evaluation of Patients with Pancytopenia: Impact of Clonal Hematopoiesis of Indeterminate Potential (CHIP)
    Fernandez-Pol, Sebastian
    Ma, Lisa
    Arber, Daniel A.
    MODERN PATHOLOGY, 2016, 29 : 344A - 344A
  • [7] CHARACTERIZATION OF SOMATIC MUTATIONS ASSOCIATED WITH CLONAL HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROME
    Toribio-Castello, S.
    Martin-Izquierdo, M.
    Hernandez-Sanchez, M.
    Lopez-Cadenas, F.
    Santos-Minguez, S.
    Miguel-Garcia, C.
    Diaz-Martin, A. B.
    Simon-Munoz, A. M.
    Martin-Martin, A.
    Davila, J.
    Alonso, J. M.
    Solana, J.
    Sanchez-Real, J.
    Ramos, F.
    Pardal, E.
    Gonzalez, T.
    Benito, R.
    Diez-Campelo, M.
    Hernandez-Rivas, J. M.
    Del Rey, M.
    HAEMATOLOGICA, 2020, 105 : 73 - 74
  • [8] Clonal hematopoiesis of indeterminate potential (CHIP) mutations in solid tumor malignancies.
    Conces, Madison
    Ni, Ying
    Bazeley, Peter
    Patel, Bhumika
    Funchain, Pauline
    Carraway, Hetty E.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [9] CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL (CHIP): INSTRUCTIONS (FOR USE)
    Malcovati, L.
    HAEMATOLOGICA, 2024, 109 : 1 - 2
  • [10] Clonal Hematopoiesis of Indeterminate Potential (CHIP) is an Independent Risk Factor for Cardiomyopathy in Patients With Solid Malignancy
    Martinez, Carlos F. Matute
    Jayakrishnan, Ritujith
    Guajardo, Ana Ferrigno
    Leveille, Etienne
    Lin, Derrick
    Im, Yunju
    Christofides, Anthos
    Chen, Nathan
    Baldassarre, Lauren A.
    VanOudenhove, Jennifer
    CIRCULATION, 2023, 148